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ABSTRACT OF THESIS 
 
 
 
 
USE OF HYBRID DIFFUSE OPTICAL SPECTROSCOPIES IN CONTINUOUS 
MONITORING OF BLOOD FLOW, BLOOD OXYGENATION, AND OXYGEN 
CONSUMPTION RATE IN EXERCISING SKELETAL MUSCLE 
 
This study combines noninvasive hybrid diffuse optical spectroscopies [near-infrared 
spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS)] with occlusive 
calibration for continuous measurement of absolute blood flow (BF), tissue blood 
oxygenation (StO2), and                             2) in exercising skeletal muscle.  
Subjects performed rhythmic dynamic handgrip exercise, while an optical probe 
connected to a hybrid NIRS/DCS flow-oximeter directly monitored oxy-, deoxy-, and 
total hemoglobin concentrations ([HbO2], [Hb], and [tHb]), StO2, relative BF (rBF), and 
           O2      2                                                              2 were 
obtained through venous and arterial occlusions, respectively, and used to calibrate 
continuous relative parameters.  Previously known problems with muscle fiber motion 
artifact in optical measurements were mitigated with a novel dynamometer-based gating 
algorithm.  Nine healthy young subjects were measured and results validated against 
previous literature findings.  Ten older subjects with fibromyalgia and thirteen age-
matched healthy controls were then successfully measured to observe differences in 
hemodynamic and metabolic response to exercise.  This study demonstrates a novel 
application of NIRS/DCS technology to simultaneously evaluate quantitative 
hemodynamic and metabolic parameters in exercising skeletal muscle.  This method has 
broad application to research and clinical assessment of disease (e.g. peripheral vascular 
disease, fibromyalgia), treatment evaluation, and sports medicine. 
 
KEYWORDS: Diffuse correlation spectroscopy; near-infrared spectroscopy; blood flow; 
blood oxygenation; oxygen consumption rate 
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CHAPTER 1: INTRODUCTION 
 
1.1  Blood Flow and Metabolism in Health and Disease 
 To produce energy for normal cellular function, living cells consume oxygen and 
produce metabolic waste via aerobic respiration.  Nutrients are supplied and waste is 
removed via diffusion through capillary membranes in the microvasculature of the 
cardiovascular system, which is regulated by many factors, both centrally (central 
nervous system) and locally (mechano-chemical response).  The balance of oxygen 
delivery and oxygen consumption is critical in maintaining homeostasis for health.  In 
order to fully understand how certain tissues function, and the regulatory mechanisms 
that maintain their homeostatic environment, it is essential to monitor both the nutrient 
supply and consumption at a local level.  As such, blood flow (BF), oxygen consumption 
rate (   2), and tissue blood oxygen saturation (StO2) can all provide useful metrics for 
evaluating tissue health and disease. 
Skeletal muscle provides an excellent platform for studying cardiovascular and 
metabolic regulation, as it comprises approximately 40% of total body mass, and under 
working conditions, can utilize up to 85% of total cardiac output [1].  Characterization of 
circulatory and metabolic function in skeletal muscle has provided key insight into the 
pathophysiology, diagnosis, and treatment of common and widespread diseases affecting 
millions of people annually (e.g., 12–14 % of older adults in U.S. with peripheral arterial 
disease [2-4], 10 million with fibromyalgia [5, 6], and 5 million with chronic heart failure 
[7-9]), causing increased health cost and impaired quality of life. 
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In addition to numerous applications to exercise physiology and sports medicine [10], 
quantification of hemodynamic/metabolic parameters has potential to characterize disease 
status by monitoring abnormalities.  Because functional impairments are not always 
apparent at rest, it is important to study hemodynamic and metabolic changes in response 
to stimulus [3, 8, 11-13].  For example, patients with peripheral arterial disease can 
exhibit normal resting blood pressures and flow, but impaired flow in following an 
exercise stress test [14].  Rhythmic exercise is an effective method for inducing changes 
in both BF and    2.  The ability to simultaneously monitor these parameters 
continuously and noninvasively during exercise has great potential for investigating 
muscle and exercise physiology, improving diagnosis and treatment assessment, as well 
as understanding pathophysiology of disease affecting skeletal muscle. 
 
1.2  Blood Flow Measurement 
 There have been several previous efforts to monitor flow non-invasively, including 
Doppler ultrasound, laser Doppler, positron emission tomography (PET), and arterial-
spin-labeled MRI (ASL-MRI) [15].  Doppler ultrasound is widely used, but is limited to 
imaging large vessels [16].  Flow through these vessels represents regional flow, which 
can obscure details found in evaluation of individual muscles [17, 18].  Laser Doppler is 
capable of monitoring flow in the small vessels of the microvasculature, but is incapable 
of penetrating to deep tissues, restricting measurement to shallow tissue (i.e. skin flow) 
[19].  PET [20] and ASL-MRI [21] are both capable of measuring flow in deep tissues, 
but require expensive and cumbersome equipment which can restrict the range of motion 
for exercise studies, and is often not practical for some laboratories or clinics.  In 
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addition, most of these technologies are sensitive to muscle motion artifact, which can 
distort signals from contracting muscle.  The limitations of these technologies have 
prevented widespread use in exercise research and clinical settings.  The need exists, 
therefore, for a noninvasive technology capable of monitoring local deep tissue blood 
flow without the restriction imposed by large expensive equipment. 
 
1.3  Blood Oxygenation Measurement 
 There are many different techniques for measuring blood oxygenation in vivo, 
including blood sampling for arterial blood gas tests (ABGs) [22], functional MRI 
(fMRI) [23], oxygen electrodes [24], spectroscopic techniques such as electron 
paramagnetic resonance (EPR), nuclear magnetic resonance (NMR) [25], and near-
infrared spectroscopy (NIRS) tissue-oximetry [26].  Concentration of metabolites in 
blood that depend on the presence of oxygen can also be used to monitor oxygen levels, 
but is an indirect secondary measurement which is also invasive [25].  ABGs are 
invasive, and are generally reflective only of arterial blood oxygenation, not local tissue 
blood oxygenation or oxygen uptake.  Oxygen electrodes are invasive and can only 
measure oxygen partial pressure (PO2) in a tiny spot, and often produce inconsistent 
results in highly heterogeneous tissues.  fMRI, EPR, and NMR are very expensive and 
cumbersome, and not frequently used in many clinical or research environments.  By far 
the most popular method for measuring blood oxygenation is NIRS tissue-oximetry.  
NIRS allows for noninvasive measurement in vivo, and advances in technology have 
made NIRS monitors inexpensive, fast, portable, and easy to use. 
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1.4                             2) Measurement 
Oxygen consumption in skeletal muscle has also been quantified by a variety of 
technologies.  Spirometry measures whole body    2, but does not provide information 
regarding the contributions of individual organs or tissues [27].  Muscle    2 can be 
determined invasively using catheterization and blood sampling, with application of the 
Fick principle [28, 29].  Blood sampling is well-established, but aside from the 
invasiveness of the procedure, the data provided remain regional in scope of O2 
dynamics.  Samples are usually taken from major vessels which perfuse groups of 
muscles, and do not assess dynamics at the level of the local microvasculature.  31-
phosphorus magnetic resonance spectroscopy (
31
P-MRS) is capable of monitoring local 
muscle oxygen kinetics, but requires expensive and cumbersome equipment which limits 
measurement during exercise, has limited sensitivity, and poor temporal resolution [30].  
Thus, there is a need for a simple method to determine local muscle    2 easily and 
noninvasively in exercising muscle. 
 
1.5  Near-infrared Spectroscopy (NIRS) 
Near-infrared (NIR) diffuse spectroscopic technologies for tissue hemodynamic 
monitoring have gained popularity in recent years, including many studies investigating 
muscle physiology [10, 31, 32].  NIR technology offers several attractive features making 
it ideal for research and clinical use, including noninvasiveness, portability, and 
inexpensiveness.  NIR light is well-suited to biomedical applications due to the low 
absorption of tissue in the spectral (600 – 950 nm) window (see Figure 1) in biological 
tissues [33].  Reduced absorption allows for deep penetration of photons into the tissue of 
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interest.  As they pass through the tissue, photons interact with scatterers (cell 
membranes, organelles, nuclei) and absorbers (deoxy- and oxy-hemoglobin, water).  In a 
scattering event, light is redirected along a new path, and in an absorbing event, light 
intensity is attenuated.  At wavelengths in the NIR range, scattering is much greater than 
absorption, and photons undergo diffusive motion as they are reflected back to the 
surface of the tissue.  Tissue optical properties are characterized by absorption and 
reduced scattering coefficients, represented by µa and µs’    
-1
 units), respectively.  
NIRS is typically categorized into three different techniques based on illumination 
type [34].  The continuous-wave (CW) paradigm uses constant illumination, and 
measures light attenuation through the tissue (see Figure 2a).  The frequency domain 
(FD) paradigm uses intensity modulated light to illuminate the tissue, and measures both 
the attenuation and the phase shift at the detector (see Figure 2b).  The time-domain (TD) 
paradigm is based on a pulse injection of light into the tissue, and the time-resolved 
measurement at the detector (see Figure 2c).  The shape of the detected pulse following 
attenuation and broadening provides property information about the propagation tissue.  
Of the techniques, CW is the simplest and least expensive, but only provides relative 
values for deoxy-, oxy-, and total hemoglobin concentrations ([Hb], [HbO2], and [tHb]).  
FD and TD techniques are capable of measuring absolute µa and µs’                    
concentrations, but are also more expensive and technologically complex.  In addition, 
the TD technique provides more spatial information about properties at differing depths, 
but at a cost to temporal resolution. 
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Figure 1. Absorption Spectra of Hemoglobin and Water 
The absorption coefficients (µa     w                   w           λ                                2), 
deoxygenated hemoglobin (Hb), and water (H2O).  Within the NIR spectral window (~600 – 900 nm), light 
is able to penetrate deep tissue due to low absorption. 
 
 
Figure 2. NIRS Modalities 
Sample input and output intensity signals representing the three types of NIRS techniques.  Panel (a) shows 
continuous wave (CW) spectroscopy, in which attenuated intensity of continuous illumination is monitored.  
Panel (b) shows frequency domain (FD) spectroscopy, in which input light is modulated and the amplitude 
attenuation and phase shifts are detected.  Panel (c) shows time domain (TD) spectroscopy, in which an 
impulse of light is emitted into the tissue, and the intensity change with respect to time is detected. In the 
figure, I represent intensity  Φ                                   the frequency of modulation. 
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1.6  Diffuse Correlation Spectroscopy (DCS) 
Diffuse correlation spectroscopy (DCS) is a relatively new technique for monitoring 
relative blood flow changes in deep tissues [33, 35, 36].  DCS takes advantage of the 
same optical window as traditional NIRS techniques, but employs a long-coherence NIR 
CW laser as the light source, and monitors speckle fluctuations at the tissue surface using 
photodetectors.  Speckle fluctuations are caused by photon interactions with moving 
scatterers, primarily red blood cells (RBCs) in the microvasculature.  Each scattering 
event causes a random scattering phase shift in the light field of the photons, and the 
superposition of multiple fields with different phases creates an interference pattern.  The 
time-dependent light intensity fluctuations can be quantified by temporal autocorrelation 
functions. 
DCS relative flow measurements are obtained by fitting experimentally obtained 
normalized temporal intensity autocorrelation functions from the speckle fluctuation to 
theoretical solutions based on the correlation diffusion equation, from which a blood flow 
index (BFI) is derived. Relative change in blood flow (rBF) can then be calculated by 
normalizing BFI to its baseline value (e.g. before physiological changes). DCS 
technology has many advantages, including noninvasiveness, portability, high temporal 
resolution, deep tissue penetration, and low running cost.  All of these features make 
DCS an attractive option for clinical studies on even fragile patient populations, as well 
as research studies in the field. 
DCS for rBF measurement has been applied to a wide variety of tissues, including 
human brain [37-42], head/neck tumor [43, 44], breast [45, 46], and muscle [47-49], and 
has been validated by a variety of local flow measurement techniques, including laser 
8 
Doppler [33, 50], Xenon-CT [39], and perfusion MRI (ASL-MRI) [33, 49].  In moving 
skeletal muscle, fiber motion during contraction can also cause scattering and introduce a 
motion artifact leading to overestimation of flow. This poses a significant problem for 
monitoring hemodynamics during physical activity [51].  Previous efforts to reduce 
motion artifact have required precise co-registration of signals with a dynamometer and 
off-line analysis [50]. 
 
1.7  Diffuse Optical Measurement Limitation and Current Study 
 It is apparent from review of literature, that there is a need for a simple method to 
noninvasively quantify local blood flow, blood oxygen saturation, and oxygen 
consumption in muscle during exercise without overly restricting movement.  NIRS 
technology is capable of monitoring absolute oxygenation in tissue, and DCS technology 
is capable of directly monitoring relative blood flow (rBF) in muscle.  Combining these 
two technologies, it is possible to derive relative oxygen consumption (r   2) based on 
the Fick principle [13] (see Section 2.4).  With such combination of multiple parameters, 
investigators and clinicians could be capable of obtaining a much clearer picture of 
muscle hemodynamics and metabolism. 
 Currently DCS-based measurements are limited to providing only relative 
information, as the flow index is calculated relative to the baseline.  To overcome this 
limitation, it is necessary to employ some method of calibration.  Absolute measurements 
of flow can be obtained readily with NIRS through venous occlusion protocols [1, 28, 52-
54].  This technique has been validated against other modalities including the clinically 
accepted method of strain-gauge plethysmography.  Although this method provides 
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absolute BF measurement, it requires interruption of natural flow response (as occlusions 
require ~10 s), which is not ideal for monitoring the rapid hemodynamic changes 
associated with exercise and recovery.  Employing this protocol at rest determines an 
absolute baseline flow which can be used to calibrate the continuous relative DCS 
measurements.  This eliminates the need for additional occlusions during exercise and 
allows for direct measurement of the natural flow response with higher temporal 
resolution.  Similarly, the derived r   2 signal can be calibrated through arterial occlusion 
[28, 55, 56].  Absolute    2 measurement can be determined by monitoring the rate at 
which muscle converts oxy-hemoglobin (HbO2) to deoxy-hemoglobin (Hb) while blood 
supply and return is occluded.  The resting baseline absolute    2 determined prior to 
exercise can then be used to calibrate the r   2 signal from the hybrid instrument. 
 Muscle motion artifact presents another limitation preventing widespread application 
of DCS-based measurement techniques to exercise study.  In order to overcome this 
limitation, it is necessary to employ a method which eliminates measurement while the 
muscle is contracting.  To address this issue, a dynamometer based gating algorithm was 
embedded into the control software of a hybrid instrument (see Chapter 2.3).  This 
algorithm uses signals generated by a dynamometer to determine the contraction status of 
muscle, and control data acquisition accordingly.   
 This study combines occlusive calibration protocols with gated NIRS/DCS 
measurements to investigate the feasibility of directly measuring absolute BF, StO2, and 
   2 in actively exercising skeletal muscle.  This method was applied to dynamic exercise 
in the forearm flexor muscles of a nine young healthy subjects.  Following validation of 
results in the young healthy population, the technique was applied to eleven fibromyalgia 
10 
patients and thirteen age-matched healthy controls to investigate differences in 
hemodynamic and metabolic responses to exercise. 
 This thesis is organized into the following chapters.  Chapter 2 discusses the theory 
behind NIRS and DCS measurements, and describes the hybrid instrument and its data 
acquisition sequence.  Chapter 3 describes the measurement protocol, beginning with an 
overview of procedure, followed by a more detailed description of each individual 
component.  The details of the gating algorithm are also described.  Chapter 4 describes 
the experimental procedures for the validation study in young healthy subjects.  Chapter 5 
details the application of the method to a fibromyalgia disease population (with age-
matched healthy controls).  Results are presented with accompanying discussion and 
critique in Chapter 6.  Finally, Chapter 7 discusses the novel contributions of this work as 
well as directions for future research. 
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CHAPTER 2: THEORY 
 
 Measurements in this study were made using a hybrid NIR diffuse optical instrument 
which combined a commercial FD NIR tissue-oximeter (the Imagent from ISS, Inc., IL, 
USA) [57], and a custom-built NIR DCS flow-oximeter [58] (see Figure 3).  These two 
devices communicate through control software in external computers to make concurrent 
measurements of tissue optical properties and blood flow indices, from which 
hemodynamic and metabolic parameters can be derived.  Parameters were evaluated in a 
young healthy population, as well as a fibromyalgia patient population with age-matched 
healthy controls.  This chapter is organized as follows.  First, the theory behind FD NIRS 
measurement of tissue optical properties and chromophore concentration calculation is 
discussed in Chapter 2.1.  Then the principles behind DCS measurement of blood flow 
indices are outlined in Chapter 2.2.  The configuration of the hybrid instrument is 
described in Chapter 2.3.                                 2 measurement is described in 
Chapter 2.4. 
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Figure 3. Hybrid Optical Instrument 
 
The hybrid optical instrument combining a commercial Imagent (ISS, Inc.) FD spatially-resolved NIRS 
oximeter and the custom-built DCS instrument.  The Imagent instrument includes 110 MHz modulated 
sources (of which the 690 and 830 nm wavelengths are used), photomultiplier tube (PMT), and desktop 
computer control, which ultimately calculates tissue optical properties (µa and µs’      deoxy-, oxy-, and 
total hemoglobin concentrations ([Hb], [HbO2], and [tHb]).  NIRS measures the modulated light amplitude 
(ac), average light intensity (dc), and phase  φ                             The DCS instrumentation includes 
an 830 nm laser source, avalanche photodiodes (APDs), autocorrelator board, and laptop computer control, 
which ultimately calculates the blood flow index (BFI).  The two alternate measurements via triggers.  
Light is delivered through optical fibers to a black probe placed on the skin surface (see Figure 4). 
 
 
2.1  NIRS for Oxygenation Measurement 
A commercial 4-wavelength (690, 750, 780, and 830 nm) FD multi-distance spatially 
resolved spectroscopy instrument (Imagent, ISS) is employed to quantify µa, µs’, [HbO2], 
and [Hb] in muscle.  Total hemoglobin concentration ([tHb]) is calculated as: [tHb] = 
[HbO2] + [Hb], and tissue blood oxygen saturation (StO2) is calculated as: StO2 = 100% · 
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[HbO2]/[tHb].  Parameters are measured using only the 690 and 830 nm wavelengths, 
modulated at 110 MHz.  NIR light is delivered to the tissue via optical source fibers, and 
backscattered photons are collected by detector fibers located a few centimeters away.  
Source and detector fibers are embedded in a black flexible probe placed on the skin 
surface.  Four source fibers per wavelength (8 total) are placed at distances of 2.0, 2.5, 
3.0, and 3.5 cm from a detector fiber bundle (see Figure 4).  The detector fibers are 
connected to a photomultiplier tube (PMT), which converts the light intensity to a voltage 
signal.  From the detected light, changes in modulated light amplitude (ac), average light 
intensity (dc), and phase shift  φ                             source-detector separation 
(r).  Through solutions to a photon diffusion equation [57], µa and µs’                
from the detected                                                φ   For a semi-infinite 
geometry, it has been found that an approximate linear relationship exists between r and 
the logarithmic ac·r
2
, logarithmic dc·r
2     φ.  These approximate relationships are 
described by the following equations [59] and adopted in the ISS Imagent instrument: 
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w     ω                   q                     v is the speed of light in the medium, D 
                                  D ≈ 1/3µs’   Kφ is the relative phase of the source plus 
any phase shifts outside the sample, Kac and Kdc are constants depending on detector 
sensitivity factors, modulation depth, and source intensity, and Indc, Inφ, and Inac are line 
intercepts from the multiple separation line fit.  Only              φ            r2·ac or 
r
2
·dc slope are necessary to obtain optical properties for each wavelength.  The 
combination of Sac and Sφ has the added advantage of reducing influence from 
background light [60].  The absorption coefficient can be decomposed into contributions 
from individual tissue chromophores by the following [33]: 

i
ia i])[λ(ε)λ(μ  (7) 
w     εi λ         w         -dependent extinction coefficient for the i
th
 chromophore, 
and [i] is the concentration for the i
th
 chromophore, to be reconstructed.  
During preliminary testing, data showed that the phase component of FD spatially 
resolved spectroscopy introduced too much noise for adequate slope fitting during BF 
calibration (see Section 3.2).  Thus, only the amplitude differences from a single source-
detector separation (2.0 cm) were used to calculate relative changes in chromophore 
               Δ[   2]  Δ[  ]                   -Lambert law [61], and added to 
absolute baselines (determined as the average of the first 10 data points). 
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Figure 4. Hybrid Optical Probe 
The configuration for the hybrid optical probe, embedded with source and detector fibers for both the 
Imagent NIRS and the DCS instruments.  Probe is of black flexible silicon, and the surface shown is placed 
in direct contact with the skin surface. 
 
2.2  DCS for Blood Flow Measurement 
 Diffuse correlation spectroscopy (DCS), also known as diffusing wave spectroscopy 
(DWS) [62], is an extension of the single scattering dynamic light scattering (DLS) 
technique to the multiple scattering limit [40].  In optically thick systems, such as 
biological tissue, light is scattered multiple times before being absorbed or leaving the 
sample.  By accounting for multiple scattering events, DCS is able to probe and obtain 
information from deep tissues.  Details regarding the complete theoretical development of 
DCS can be found elsewhere [63]. 
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 DCS uses a single CW laser (830 nm) with long coherence length (> 5 meter) to emit 
photons into the tissue through a multimode optical fiber embedded in the same black 
flexible probe as the FD NIRS fibers (see Figure 4).  Four single-mode detector fibers at 
a specified distance away measure light speckle fluctuations at the surface caused by 
moving scatterers (primarily red blood cells).  The photons are detected and counted by 
avalanche photodiodes (APDs, PerkinElmer Inc., Canada), and its output is fed to an 
autocorrelator board (correlator.com, NJ).  The autocorrelator determines the normalized 
light intensity temporal autocorrelation function, g2(r,τ) [40]:   
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r           (8) 
where I(t) is the intensity at time t, the angular brackets denote temporal average, r is the 
general vector from the source to a point of detection, and τ is the delay time.   The 
g2(r,τ) functions from the four detectors are averaged together to improve the signal-to-
noise ratio (SNR).  The normalized intensity temporal autocorrelation function is then 
related to the normalized electric field autocorrelation function (g1(r τ   via the Siegert 
relationship [64]: 
    212 ,1,  rr gg            (9) 
where β depends on laser stability, coherence length, and detection optics, and is 
inversely proportional to the number of speckles detected.  β is determined 
experimentally for each measurement from the intercept of g2(r  τ     τ → 0  
Light diffusion in highly scattering media is characterized by the correlation diffusion 
equation, which is rigorously derived elsewhere [35, 40, 63]: 
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where D ≈ v/(3µs
’
) is the photon diffusion coefficient, v is the speed of light in the 
medium, k0 = 2π /λ        w   vector of photons in the medium, and S0(r) is the source-
light distribution.  The term <Δr2 τ >            -square displacement of scatterers in 
     τ                 effective “          "                 q        G1(r τ         
unnormalized electric field autocorrelation function.  The normalized electric field 
autocorrelation function is determined as g1(r τ  = G1(r τ /G1(r,0).  The homogenous CW 
solution to Eq. 10 for a semi-infinite geometry is: 
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where ρ is the source-detector separation distance, S0 is the source intensity, 
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s effeffb RRz  , nnnReff 0.06360.6680.7101.440
12   .  
Reff accounts for the mismatch of refractive indices between air and the medium, with n as 
the ratio between them.  For biological tissue, n ≈ 1 33 [33].  For a semi-infinite 
                                             0  0  0                       ρ  0  0   w        
tissue surface being in the z = 0 plane (see Figure 5). 
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Figure 5. Tissue Absorption and Scattering 
The source and detector placement on the tissue surface.  Solid circles with gray arrows represent moving 
scatterers (RBCs).  Black and light gray lines indicate potential photon paths. 
 
 The movement of dynamic scatterers in biological tissue is characterized by Brownian 
motion, <Δr2 τ > = 6DBτ  w     DB is the effective Brownian diffusion coefficient.  The 
                                      α                             w                      
                       αDB represents a blood flow index (BFI), which is used to 
determine relative blood flow (rBF) by comparison with the baseline resting BFI: 
baselineBFI
BFI
rBF               (12) 
To quantify the BFI, first g2 ρ τ                                         ~26             
autocorrelator board.  This measurement is repeated multiple times within a given period 
(300 ms), and the g2 ρ τ                         to achieve sufficient signal-to-noise 
ratio.  The measured intensity autocorrelation curve is then transformed to the electric 
field autocorrelation curve, g1 ρ τ          S                     Eq. 9).  The experimental 
g1 ρ τ  is then fit with the theoretical solution of the correlation diffusion equation (Eq. 
10 and Eq. 11)             αDB and using a least mean squares approach.  The overall 
process of DCS measurement is shown in Figure 6. 
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Figure 6. DCS Measurement and Analysis 
A step-by-step guide to DCS measurement and analysis.  First, the laser illuminates the tissue, and photon 
speckle fluctuations are captured with the APDs.  The data are sent to an autocorrelator board, which 
calculates the temporal intensity autocorrelation function, g2 τ    T                               z   
temporal electric field autocorrelation function, g1 τ           S                      T             1 τ     
         w                                       αDB, which is also the blood flow index (BFI).  From the 
BFI, rBF can be determined by normalizing to the baseline. 
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2.3  The Hybrid Instrument 
 The Imagent NIRS instrument and the DCS instrument were combined into a single 
hybrid device known as a hybrid tissue flow-oximeter (see Figure 3).  This device has 
been described in detail elsewhere [58], and is capable of collecting data from either 
device individually or collectively by alternating sequentially between the two.  When 
operating in tandem, a single acquisition sequence first begins with activation of the DCS 
laser, followed by data collection from the autocorrelator.  The acquired data with 
individual autocorrelation functions is stored in a .dat file for later offline data analysis.  
The DCS laser is then deactivated, and notification is sent to the Imagent via a TTL 
trigger to begin NIRS data acquisition.  NIRS acquisition begins with activation of a 
single 830 nm laser (4 in total) at a given source-detector separation (2.0, 2.5, 3.0 or 3.5 
cm), followed by data collection from the PMT.  Data collection iterates through 
sequential activation of each 830 nm laser (for a given source-detector separation).  After 
data collection, the 830 laser is deactivated, and the sequence repeats for the 690 nm 
lasers.  When a single round of data collection is completed for each laser at each 
separation, ac, dc, and phase data are stored in a .txt file.  This .txt file can then later be 
analyzed by supplemental processing to calculate parameters such as µa and µs’  w     
are saved in a user generated .log file.  A control signal is then sent to the DCS to 
reinitiate the entire cycle.  Data acquisition times are modifiable based on input 
parameters.  Specific acquisition times for each protocol are detailed in the following 
chapters.   
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2.4     2 Derivation 
 To determine the absolute oxygen                      2                              
                2      2) is calculated from tissue oxygen saturation (StO2              
   S                     D S       ’    w                2 is equal to the blood flow 
times the arterio-venous oxygen difference:  
)]O[]([O  BFOV v2a22 
          (13) 
where [O2]a is the arterial oxygen concentration, and [O2]v is the venous oxygen 
concentration.  The percentage of oxygen extracted, or the oxygen extraction fraction 
(OEF) can be defined as: OEF = ([O2]a – [O2]v)/[O2]a.  Com            w                 
 q           2 can be defined by the following equation:  
a22 ])([OBFOEFOV 
          (14) 
                                       2, rOEF, rBF, r[O2]a) can be determined by 
dividing by the respective baseline value, so Eq. 14 becomes:  
)](r[OrBFrOEFOVr a22 
         (15) 
Making the assumption that [O2]a does not change [13], the equation is reduced to:  
rBFrOEFrBF            (16) 
OEF is related to tissue oxygen saturation by the following:  
)OSγ(
)OSO(S
OEF
2a
2t2a


           (17) 
where SaO2 and StO2                                          γ                     
percentage of blood volume contained in the venous compartment of the vascular system 
[65, 66]                                        γ                  constant (see Section 
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6.3).  If SaO2 is also assumed to be a constant 100%, which has been found to be a 
reasonable approximation [13, 67], then Eq. 17 becomes:  
)OS1(
)OS (1
rOEF
2baselinet
2t


          (18) 
Substituting this into Eq. 16      2 can be calculated as: 
)OS(1
)OS(1
rBFOVr
2baselinet
2t
2


           (19) 
StO2 is measured directly with NIRS, and rBF is measured directly with the DCS, thus 
    2 can be measured by the hybrid instrument. 
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CHAPTER 3: MEASUREMENT PROTOCOL 
 
The measurement protocol is divided into three distinct sub-protocols: venous 
occlusion for baseline absolute BF calculation, arterial occlusion for baseline absolute 
   2 calculation, and the exercise protocol for modulation of BF,    2, and StO2.  This 
chapter is divided as follows:  First, there is an introduction to the overall measurement 
protocol in Chapter 3.1.  Specifics of the calibration calculations are addressed in Chapter 
3.2, and the exercise protocol is described in Chapter 3.3.  Finally, the gating algorithm 
used during exercise is described in Chapter 3.4. 
 
3.1 Measurement Protocol Overview 
Following the methods detailed in previous work [1, 55, 68], three different protocols 
were used in this study to obtain absolute BF, StO2, and    2 in the forearm flexors 
during exercise.  First, venous occlusion at 50 mmHg was applied on upper arm to obtain 
absolute baseline BF [1].  Second, arterial occlusion at 240 mmHg was applied to obtain 
absolute baseline    2 [55].  Third, muscle BF and    2 were manipulated by 5 minutes 
of rhythmic handgrip exercise at a fraction of the maximal voluntary contraction (MVC) 
[68] to test the capabilities of using the hybrid optical device for quantifying absolute BF 
and    2 continuously during exercise.  During all protocols, a black, flexible fiber-optic 
probe (see Figure 4) was taped to the skin surface above the forearm flexor muscles 
(flexor digitorum superficialis/profundus).  This probe allowed for transmission of 
photons to the tissue via source fibers, and detection of backscattered photons at the 
tissue surface via detector fibers.   
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Before the optical probe was fixed, subjects were instructed to lie supine with the right 
arm extended, slightly elevated above heart level (< 20°).  Elevation prevents pooling of 
the blood and facilitates venous return (see Figure 7).  Elbow flexion was kept as close to 
0° as possible.  Resting blood pressure was obtained using an automatic monitor (Omron 
HEM-80, Kyoto), and skin/adipose tissue thickness at the probe site was measured with 
skinfold calipers (Lange 85300, TX).   
First, individual MVC was determined for each subject by incremental isotonic 
handgrip exercise.  Healthy subjects squeezed a handgrip device on a dynamometer (BTE 
PrimusRS, MD) through a distance of 5 cm for an increasing load until they were unable 
to perform the task.  Initial load was set at ~20 N·m with an incremental increase of ~5 
N·m.  In most subjects, MVC could be determined within 4 contractions, minimizing the 
effect of fatigue or potentiation.  Following MVC testing, the dynamometer load was 
reduced to a fraction of the MVC, and subjects completed a very brief training period (< 
15 repetitions) to familiarize themselves with the contraction rhythm during the exercise 
protocol.  A visual metronome on the dynamometer monitor aided subjects in keeping 
pace, and subjects were able to complete the exercise protocol at the set rhythm without 
difficulty.  Subjects were then instructed to rest while the optical probe was taped to the 
right forearm and a fast-inflating automatic tourniquet cuff (Zimmer ATS 1000, IN) was 
placed on the right upper arm just above the elbow. 
During the venous occlusion protocol, 1 minute baseline measurement was recorded, 
followed by three repetitions of 10 s occlusion (50 mmHg) separated with 30 s rest.  For 
the arterial occlusion protocol, another 1 min baseline was recorded, followed by a 3-
minute arterial occlusion (240 mmHg).  Following the release of the arterial cuff, 5 
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minutes recovery data were collected to ensure hemodynamic recovery to baseline.  After 
baseline had been reestablished, subjects performed 5 minutes handgrip exercise 
following the rhythm described above.  Five minutes recovery data were then recorded.  
Data acquisition parameters and protocols are discussed in detail in the following 
sections. 
 
 
 
Figure 7. Arm Positioning and Probe Fixation during Protocol 
During all protocols, subject was supine with the right arm extended slightly elevated above heart level (< 
20°) to prevent pooling and facilitate venous return.  The hand maintained the grip position, around the 
dynamometer attachment.  The hybrid optical probe (see Figure 4) was taped to the forearm flexor muscles 
(flexor digitorum superficialis/profundus) following MVC test, prior to occlusions. 
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3.2  Calibration of Relative Signals with Absolute Baseline BF and    2 
 The relative blood flow (rBF) signal acquired from the DCS was calibrated in this 
study by using venous occlusion in conjunction with NIRS measurement.  Venous 
occlusion plethysmography is a widely accepted method for determining peripheral blood 
flow [15, 69], and has been used frequently in recent years with NIRS techniques [1, 28, 
53, 70].  This technique has been applied on both resting and exercising muscle, and has 
been validated against the more conventional standard of strain-gauge plethysmography 
[1, 28].  During venous occlusion, a fast-inflating tourniquet cuff is applied to the upper 
arm just above the elbow and inflated to a pressure greater than the venous pressure, but 
lower than diastolic arterial pressure.  Pressure between 30 – 60 mmHg gives the most 
reproducible results [71], and the most common convention is to use 50 mmHg (used in 
this study).  By inflating the cuff to this pressure, venous outflow is occluded while 
arterial inflow is permitted, causing a total blood volume increase in the arm.  This is 
recorded by NIRS measurements as an increase in [tHb] (see Figure 8).  The initial rate 
of increase (~5 s) is directly proportional to the arterial inflow.  BF is calculated by the 
following equation [72]: 
dt
d ]tHb[
C
1
BF            (20) 
where C is the hemoglobin concentration of whole blood.  In this study, a standard value 
of 14.1 g/dL [73] was used for C, but individual concentrations may be measured 
invasively through blood samples, obtained from patient records, or measured 
noninvasively via pulse CO-oximetry (Masimo, Inc., CA) [74].  [tHb] is converted from 
molar concentration to blood volume by multiplying by the molecular weight of 
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hemoglobin (64,458 g/mol) [75], and dividing by C.  Absolute BF is expressed in units of 
ml blood per 100 ml tissue per minute [ml/100 ml/min].  
 
 
Figure 8. Slope Fitting during Venous Occlusion for Absolute BF Calculation 
The [tHb] increase induced by 50 mmHg venous occlusion is fit with linear regression.  The initial slope of 
the fitted line (~5 s) is indicative of the muscle BF (see Eq. 20).  Vertical lines indicate application and 
release of venous pressure. 
 
During the venous occlusion protocol, only NIRS data (without DCS) were collected 
at a sampling rate of 3.7 Hz.  Only amplitude data were used in order to eliminate noise 
contributed by the phase component of the acquired data (see Section 2.1).  Preliminary 
testing showed that this high sampling rate was adequate to precisely fit the [tHb] curve 
during venous occlusion measurements.  One minute of baseline data were recorded prior 
to any venous occlusion.  After baseline data acquisition, three venous occlusions were 
performed for 10 s each, with 30 s rest between each occlusion, and a 30 s recovery 
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period following the last occlusion.  The baseline BF was then determined by averaging 
the three venous occlusion measurements. 
 Relative    2 (r   2, derived in Section 2.4) was calibrated in this study by observing 
the rate of oxygen desaturation ([HbO2] – [Hb]) during the first 60 s of arterial occlusion 
[55].  During arterial occlusion, a fast-inflating tourniquet cuff is applied to the upper arm 
just above the elbow and inflated to a pressure significantly greater than systolic arterial 
pressure (240 mmHg used in this study).  This maneuver causes a total interruption of the 
blood supply (i.e. oxygen supply), while the tissue continues to consume oxygen.     2 is 
then proportional to the rate of oxygen desaturation ([HbO2] – [Hb]), measured by NIRS 
(see Figure 9).  Molar concentration of hemoglobin is converted to O2 volume by 
multiplying by the O2 molecular weight (32 g/mol) and the ratio of O2 to hemoglobin 
(4:1), and dividing by the O2 density (1.429 g/L).  Tissue volume is converted to mass by 
dividing by the muscle density (1.04 kg/L) [53].     2 is then expressed as ml O2 per 100 
g muscle per minute [ml O2/100 g/min].  
For the arterial occlusion protocol, alternating NIRS measurements were combined 
with DCS measurements.  While not used directly to calculate baseline    2, DCS 
measurements provided validation that BF was adequately occluded.  DCS sampling time 
was ~300 ms while NIRS sampling time was ~400 ms (~700 ms total sampling time per 
data point).  The arterial occlusion protocol consisted of 1 minute resting baseline data, 
followed by a 3-minute arterial occlusion.  Only the first 60                              
          w                                2 (see Figure 9).  Following release of the 
tourniquet, 5 minutes of resting recovery data were recorded. 
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Figure 9. Slope Fitting during Arterial Occlusion for Absolute    2 Calculation 
The saturation decrease induced by 240 mmHg arterial occlusion is fit with linear regression.  The slope of 
the fitted line during the first 60 s of occlusion                                2.  Vertical lines indicate 
application and release of arterial pressure. 
 
3.3  Exercise Protocol  
 Following the release of the tourniquet and 5 minutes recovery from the arterial 
occlusion protocol, the software gating algorithm was engaged (see Section 3.4), and 
young healthy subjects (n = 9) were instructed to perform 5 minutes of handgrip exercise 
at 25% MVC (6.8 ± 0.6 N·m) at a rate of 1s contraction (~0.5 s to contract, ~0.5 s to 
release) followed by 1 s rest.  At this submaximal exercise intensity, muscle is 
sufficiently                                 /   2/StO2 without inducing obvious post-
exercise hyperemic response [68]. This exercise protocol is in line with many other 
similar studies [1, 76, 77] to allow a basis for comparison of results.  Each subject 
therefore performed 150 contraction cycles.  Data were acquired during the relaxation 
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phase of exercise.  Sampling times were the same as used for the arterial occlusion 
protocol (~300 ms DCS, ~400 ms NIRS, for ~700 ms total).  Following exercise, the 
gating algorithm was disengaged, and 5 minutes of recovery kinetics were recorded. 
 For the fibromyalgia subjects (n = 11) and their healthy control counterparts (n = 13), 
a modified exercise protocol was used.  Differing from the exercise protocol described 
above, dynamic exercise for these subject populations was performed at 50% MVC, at a 
rate of 15 contractions/minute (1 s contract, 1 s release, 2 s rest for each contraction 
cycle).  Preliminary testing in 3 subjects in this older subject population showed that the 
slower rhythm of this contraction cycle was easier to follow than the 30 
contractions/minute rhythm used in the young healthy population.  To account for the 
slower cycle, the delay time used in the gating algorithm was 100 ms.  Other data 
acquisition times were the same as that described in the preceding sections. 
 
3.4  Embedded Gating Algorithm to Reduce Motion Artifact 
 Previous work in the field of diffuse correlation spectroscopy (DCS) has been limited 
by the fact that muscle contraction produces a signal artifact which can significantly 
overestimate flow [50].  To eliminate this motion artifact, a gating algorithm was 
embedded into the DCS data acquisition control software.  This algorithm read analog 
voltage output signals from the dynamometer to determine periods of contraction and 
relaxation in the rhythmic exercise cycle.  Once the output voltage exceeded a specified 
threshold indicating the transition from contraction (low voltage) to relaxation (high 
voltage), a trigger was initiated.  The trigger allowed for a short delay (50 ms, specified 
by user) to account for any residual motion, then initiated data acquisition.  After a frame 
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of data was recorded and stored, the software waited for the next rising edge in the 
dynamometer signal to reinitiate measurement.  Input and control signals for the gating 
algorithm are shown in Figure 10. 
 
 
Figure 10. Input and Control Signals for Gating Algorithm 
The output signals from the dynamometer and the software-generated signals that control the gating 
algorithm are shown.  The dynamometer voltage mirrors the handgrip position, indicating contraction 
status of the muscle.  Once the dynamometer voltage passes a threshold on the rising edge, the algorithm 
generates a trigger signal, which injects a small delay (to account for residual muscle tension/contraction) 
before initiating data acquisition.  Data acquisition occurs between contractions, while the muscle is at rest.  
Following a data acquisition sequence, the algorithm pauses, waiting for the next rising edge in the 
dynamometer voltage. 
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CHAPTER 4: VALIDATION IN YOUNG HEALTHY SUBJECTS 
 
 The measurement protocol developed in this study was first used in a young healthy 
population and validated against previous literature results.  Presentation of the results is 
ordered in the following manner.  First, the physical characteristics of the population are 
described in Chapter 4.1.  The effect of the embedded gating algorithm is then evaluated 
in Chapter 4.2.  Next, the typical individual hemodynamic/metabolic response during the 
course of the entire measurement protocol is presented in Chapter 4.3, as well as the 
average results of BF,    2, and StO2 for all subjects during exercise in Chapter 4.4.   
 
4.1 Young Healthy Subject Physical Characteristics 
 Nine healthy subjects (5 males, 4 females) volunteered to participate in this study 
following written consent in accordance with the University of Kentucky Institutional 
Review Board guidelines.  Physical characteristics for the sample population were (mean 
± SE) age 24.6 ± 0.6 yr, height 167.9 ± 2.5 cm, and weight 73.8 ± 8.2 kg (BMI 22.9 ± 
3.2).  Resting systolic arterial pressure was 116.2 ± 3.1 mmHg, skin/adipose tissue 
thickness (ATT) was 1.5 ± 0.2 mm, and  MVC was 27.3 ± 0.6 N·m. 
 
4.2  Effect of Gating Algorithm on Motion Artifact 
 Preliminary experimentation showed that the software gating algorithm was effective 
in removing a majority of the noise associated with motion artifact.  Figure 11 shows 
D S    w        αDB) raw signals acquired during exercise both without (Figure 11a), 
and with (Figure 11b) the gating algorithm.  The two trials were performed on the same 
subject, at the same rate and intensity (25% MVC) as the exercise protocol for young 
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healthy subjects detailed in Section 3.3.  The trials were separated by several minutes (> 
6 minutes) to ensure BF and oxygenation recovery to baseline.  The results clearly 
demonstrate the efficacy of the algorithm at removing noise due to motion artifact from 
the raw data signal.   
 
  
Figure 11. Motion Artifact Reduction with Application of Gating Algorithm 
Raw DCS data acquired during exercise protocol (see Section 3.3).  Panel (a) shows data collected without 
the gating algorithm running.  Panel (b) shows data collected with the application of the algorithm.  Raw 
data are              αDB, the blood flow index.  The vertical lines indicate the beginning and end of the 
exercise protocol. 
 
4.3  Typical Individual Response 
 The typical muscle hemodynamic response for the entire protocol is shown for a single 
subject in Figure 12.  Vertical lines denote the beginning and ending of physiological 
manipulations (occlusions, exercise).  Dark bold lines superimposed on the data signals 
indicate slope fitting during both venous and arterial occlusions.  During the venous 
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occlusions (VO), [tHb] increased at a rate proportional to the arterial inflow (see Section 
3.2).  Baseline BF for this subject obtained from the three venous occlusions was 2.48 ± 
1.14 ml/100 ml/min.  During arterial occlusion (AO), [tHb] remained constant, while the 
desaturation ([HbO2] – [Hb]) decreased at a rate proportional to    2 (see Section 3.2).  
Correspondingly, there was a noticeable decrease in tissue oxygen saturation (StO2), and 
the rBF signal from the DCS decreased to near zero.  Baseline    2 obtained from arterial 
occlusion was 0.11 ml O2/100 g/min (5.04 µmol O2/100 g/min).  During the exercise 
             2 increased, corresponding to a decrease in StO2, and an increase in rBF to 
satisfy the metabolic demand.  The absolute BF,    2, and StO2 during exercise are 
shown in Figures 13, 14, and 15 for the same subject.   
 
4.4  Average Population Response 
 All subjects demonstrated similar trends during occlusion and exercise.  Resting 
baseline BF for the 9 subjects (mean ± SE) obtained via venous occlusion was 1.76 ± 
0.40 ml/100 ml/min.  Baseline    2 obtained by arterial occlusion was 0.12 ± 0.02 ml 
O2/100  /     5 62 ± 1 03 μ     2/100 g/min), and baseline StO2 was 68.0 ± 1.0%.  To 
clearly see the general response to exercise, the filtered BF,    2, and StO2 signals were 
averaged across the subject population at 10 s time intervals throughout the protocol.  
The averaged exercise data are shown in Figures 16, 17, and 18.  Pre-exercise BF value 
was 1.76 ± 0.42 ml/100 ml/min, determined as the average of data points 30 s before the 
beginning of exercise.  This pre-exercise BF does not differ significantly from resting BF, 
indicating that there was no residual hyperemic response from arterial occlusion.  Pre-
exercise    2 value was 0.11 ± 0.03 ml O2/100 g/min, the same as the average resting 
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baseline value, and pre-exercise StO2 value was 71.9 ± 1.9%.  During exercise, BF 
increased rapidly during the first few minutes, then increased following a more 
exponential pattern to a gradual plateau.  The    2 dynamics during exercise mirrored 
this response with initial linear increase followed by exponential increase to a gradual 
plateau.  Plateau values were determined as the average of data points 30 s before the end 
of exercise.  For the 9 subjects, average plateau BF was 8.93 ± 2.81 ml/100 ml/min, 
plateau    2 was 0.57 ± 0.13 ml O2/100 g/min, and plateau StO2 was 64.0 ± 2.2%. 
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Figure 12. Hemodynamic Response in a Single Subject during Entire Protocol 
Data collected for a single subject for the entire measurement protocol.  Panel (a) shows [HbO2], [Hb], and 
[tHb] response during three 50 mmHg venous occlusions (VO).  The vertical lines denote the beginning 
and end of each occlusion.  Panel (b) shows [HbO2], [Hb], [tHb], desaturation ([HbO2] – [Hb]), StO2, and 
rBF responses during arterial occlusion (AO) and exercise (Ex).  The pairs of vertical lines denote the 
beginning and end of AO and Ex. 
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Figure 13. Absolute BF Response during Exercise in a Single Subject 
The absolute BF response in an individual subject during exercise.  The vertical lines denote the beginning 
and end of exercise.  Residual noise prior to exercise may be caused due to involuntary muscle contractions 
in preparation for physical activity before the gating algorithm had been initiated. 
 
 
Figure 14.             2 Response during Exercise in a Single Subject 
T               2 response in an individual subject during exercise.  The vertical lines denote the 
beginning and end of exercise. Residual noise prior to exercise may be caused due to involuntary muscle 
contractions in preparation for physical activity before the gating algorithm had been initiated. 
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Figure 15. StO2 Response during Exercise in a Single Subject 
The StO2 response in an individual subject during exercise.  The vertical lines denote the beginning and end 
of exercise. The slight increase in StO2 prior to exercise may be caused by increased flow from involuntary 
muscle contractions in anticipation to exercise, before oxygen demand increased. 
 
 
Figure 16. Average Population Absolute BF Response during Exercise 
The average absolute BF response of 9 healthy young subjects during exercise.  For clarity, data were 
filtered and averaged at 10 s time intervals.  The vertical lines denote the beginning and end of exercise.  
Average pre-exercise BF value was 1.76 ± 0.42 ml/100 ml/min, determined as the average of data points  
30 s before onset of exercise.  Plateau BF value was determined as the average of data points 30 s before 
the end of exercise.  For the 9 subjects, average plateau BF was 8.93 ± 2.81 ml/100 ml/min. 
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Figure 17.                                2 Response during Exercise 
T                       2 response of 9 healthy young subjects during exercise.  For clarity, data were 
filtered and averaged at 10 s time intervals.  The vertical lines denote the beginning and end of exercise.  
Average pre-exercise    2 value was 0.11 ± 0.03 ml O2/100 g/min, determined as the average of data points 
30 s before onset of exercise.  Plateau    2 value was determined as the average of data points 30 s before 
the end of exercise.  For the 9 subjects, average plateau    2 was 0.57 ± 0.13 ml O2/100 g/min. 
 
Figure 18. Average Population StO2 Response during Exercise 
The average StO2 response of 9 healthy young subjects during exercise.  For clarity, data were filtered and 
averaged at 10 s time intervals.  The vertical lines denote the beginning and end of exercise.  Average pre-
exercise StO2 value was 71.9 ± 1.9%, determined as the average of data points 30 s before onset of exercise.  
Plateau StO2 value was determined as the average of data points 30 s before the end of exercise.  For the 9 
subjects, average plateau StO2 was 64.0 ± 2.2%. 
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CHAPTER 5: APPLICATION TO DISEASE POPULATION 
 
 Chapter 5 outlines the application of the developed technique to investigation of 
fibromyalgia, a clinical disease of unknown etiology.  Both subjects diagnosed with 
fibromyalgia, as well as age-matched healthy controls were investigated.  The chapter 
opens with a review of the disease, and studies that have previously assessed flow and 
metabolism in affected populations in Chapter 5.1.  The subject population demographics 
are then detailed in Chapter 5.2, and the results are presented in Chapter 5.3.   
 
5.1  Hemodynamics and Metabolism in Fibromyalgia 
 Fibromyalgia (FM) is a chronic pain syndrome, characterized by widespread muscle 
pain and stiffness, aching, and fatigue.  FM has been generally described as 
musculoskeletal pain in the absence of other apparent organic disease [78], and in 1990 
the American College of Rheumatology committee established diagnosis criteria 
including history of widespread pain, and tenderness to digital palpitation at 11 of 18 
specified tender sites [79].  FM affects approximately 2% of the U.S. population, and is 
approximately 7 times more prevalent in women than in men [80].  The pathophysiology 
of FM is unknown, but likely involves neurological, neuroendocrine, musculoskeletal, 
and psychological components [81].   
 FM treatments tend to be only partially effective, and target symptomatic relief, 
rather than the underlying cause.  Therapies include pharmacological management [6], as 
well as exercise [82], hyberbaric oxygen therapy [83], and nitric oxide stimulants [84].  A 
commonality among partially effective treatments is a vasodilatory effect.  This, in 
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addition to the qualitative description of FM pain as being similar to pain in muscles 
following heavy exercise or anaerobic metabolism, has led to the hypothesis that the pain 
of FM may be caused in part by vasomotor dysregulation or metabolic abnormality [84]. 
Although challenged, several studies have found apparent impairments in BF [5, 85-
90] and metabolism [91-95] of FM subjects.  These studies have independently explored 
hemodynamic/metabolic parameters using Doppler ultrasound [5], laser Doppler [86, 90], 
biopsy [85, 89, 91, 92], dynamic fluorescence videomicroscopy [87], laser fluxmetry 
[88], electrodes [93], and 
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P-MRS [95].  While some studies have used these methods in 
combination to investigate BF and metabolism in resting muscle [86, 89]                  
                                             2, and StO2 noninvasively during exercise 
in skeletal muscle of FM subjects. 
The ability to monitor multiple hemodynamic and metabolic parameters 
simultaneously in response to exercise stimulus may open research options and have the 
potential to help elucidate the underlying mechanisms in FM and thus lead to more 
effective methods of treatment.  Using the method developed in this thesis, eleven 
women diagnosed with FM and thirteen    -                         w                 
       2, and StO2 changes during 50% MVC dynamic handgrip exercise. 
 
5.2  Physical Characteristics of Subjects 
 Initially, eleven subjects diagnosed with FM and thirteen age-matched healthy controls 
(HC) were voluntarily recruited to participate in this study following written consent in 
approval with the University of Kentucky Institutional Review Board guidelines.  One 
FM subject recruited for evaluation was excluded from data analysis due to excessive 
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ATT thickness (10 mm) which affected light penetration into the muscle. Therefore, data 
are presented for only 10 subjects.  Only female subjects were recruited for this study.  
Physical characteristics for the sample population (mean ± SE) are given in Table 1.  In 
all parameters except MVC, no significant differences were found between populations.  
The MVC for HC subjects was slightly lower than that for young healthy subjects, while 
the MVC of FM subjects was significantly lower than both healthy populations.  
 
Table 1.  Physical Characteristics of Fibromyalgia (FM) Subjects  
and Age-Matched Healthy Controls (HCs) 
 
Parameter HC (n = 13) FM (n = 10) 
p-value 
        ’   -test) 
Age (yrs) 57 ± 1.2 60 ± 2.3 0.2163 
BMI 25.1 ± 0.8 24.4 ± 1.1 0.5849 
Syst. BP (mmHg) 123.7 ± 3.9 125.4 ± 3.1 0.7354 
ATT (mm) 2.9 ± 0.4 2.9 ± 0.4 0.9945 
MVC (N·m)  24.14 ± 0.84 15.31 ± 1.23 <0.0001* 
 
 
5.3  Typical Individual Response 
 The typical muscle hemodynamic/metabolic response for the exercise protocol is 
shown for a single HC and FM subject in Figures 19, 20, and 21.  Vertical lines denote 
the onset and end of exercise.  Pre-exercise BF, measured as the average of points 30 s 
before the onset of exercise was 1.60 and 1.62 ml/100 ml/min for the HC and FM 
subjects, respectively.     -            2 was 0.03 and 0.04 ml O2/100 g/min, and pre-
exercise StO2 was 70.1 and 72.3%.  Plateau BF, measured as the average of points 30 s 
before the end of exercise was 10.88 and 3.16 ml/100 ml/min for HC and FM subjec   
              w                2 was 0.30 and 0.12 ml O2/100 g/min, and StO2 was 59.9 
and 68.7%.  D                                2 increased, corresponding to a decrease in 
StO2, and an increase in BF to satisfy the metabolic demand.   
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Figure 19. Individual HC and FM BF Response to Exercise 
Raw absolute BF data in response to exercise for both a single HC subject and FM subject are shown.  
Vertical lines indicate the beginning and end of exercise.  Pre-exercise BF value was 1.60 ml/100 ml/min 
for the HC subject and 1.62 ml/100 ml/min for the FM subject.  Plateau BF values were 10.88 and 3.16 
ml/100 ml/min for the HC and FM subjects, respectively. 
 
 
Figure 20.                        2 Response to Exercise 
Raw             2 data in response to exercise for both a single HC subject and FM subject are shown.  
Vertical lines indicate the beginning and end of exercise.  Pre-exercise    2 value was 0.03 ml O2/100 
g/min for the HC subject and 0.04 ml O2/100 g/min for the FM subject.  Plateau    2 values were 0.30 and 
0.12 ml O2/100 g/min for the HC and FM subjects, respectively. 
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Figure 21. Individual HC and FM StO2 Response to Exercise 
Raw StO2 data in response to exercise for both a single HC subject and FM subject are shown.  Vertical 
lines indicate the beginning and end of exercise.  Pre-exercise StO2 value was 70.1% for the HC subject and 
72.3% for the FM subject.  Plateau StO2 values were 59.9 and 68.7% for the HC and FM subjects, 
respectively. 
 
5.4  Average Population Response 
Subject data from both demographics demonstrated similar trends during occlusion 
                                       j   ’      StO2         2 data were not used 
following the 380 s time point, due to signal contamination from excessive movement by 
the subject                                             T                          
                                       2, and StO2 signals were averaged across the 
subject population at 10s time intervals throughout the protocol.  The averaged exercise 
data are shown in Figures 22, 23, and 24                                               -
                             2, and StO2 values are summarized in Table 2. 
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Figure 22. Average HC and FM Population BF Response to Exercise 
The average absolute BF response to exercise of 10 subjects with fibromyalgia (FM) and 13 age-matched 
healthy controls (HC).  For clarity, data were filtered and averaged at 10 s time intervals.  The vertical lines 
indicate the beginning and end of exercise.  Average pre-exercise BF value, determined as the average of 
data points 30 s before the onset of exercise, was 3.19 ± 1.03 ml/100 ml/min for the HC subjects and 2.63 ± 
0.71 ml/100 ml/min for the FM subjects (p = 0.444).  Plateau BF values were determined as the average of 
data points 30 s before the end of exercise.  Plateau BF value, determined as the average of points 30 s 
before the end of exercise was 10.71 ± 3.91 ml/100 ml/min for HC subjects and 4.83 ± 1.42 ml/100 ml/min 
for FM subjects (p = 0.018).                                          j   ’       were no longer used for 
averaging, due to signal contamination. 
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Figure 23.                                2 Response to Exercise 
T                       2 response to exercise of 10 subjects with fibromyalgia (FM) and 13 age-matched 
healthy controls (HC).  For clarity, data were filtered and averaged at 10 s time intervals.  The vertical lines 
indicate the beginning and end of exercise.  Average pre-exercise    2 value, determined as the average of 
data points 30 s before the onset of exercise, was 0.07 ± 0.02 ml O2/100 g/min for the HC subjects and 0.08 
± 0.03 ml O2/100 ml/min for the FM subjects (p = 0.690).  Plateau    2 values were determined as the 
average of data points 30 s before the end of exercise.  Plateau    2 value, determined as the average of 
points 30 s before the end of exercise was 0.35 ± 0.09 ml O2/100 g/min for HC subjects and 0.16 ± 0.05 ml 
O2/100 g/min for FM subjects (p = 0.002).                                j   ’       were no longer used 
for averaging, due to signal contamination. 
 
. 
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Figure 24. Average HC and FM Population StO2 Response to Exercise 
The average absolute StO2 response to exercise of 10 subjects with fibromyalgia (FM) and 13 age-matched 
healthy controls (HC).  For clarity, data were filtered and averaged at 10 s time intervals.  The vertical lines 
indicate the beginning and end of exercise.  Average pre-exercise StO2 value, determined as the average of 
data points 30 s before the onset of exercise, was 68.0 ± 1.6% for the HC subjects and 67.9 ± 0.93% for the 
FM subjects (p = 0.947).  Plateau StO2 values were determined as the average of data points 30 s before the 
end of exercise.  Plateau StO2 value, determined as the average of points 30 s before the end of exercise was 
57.1 ± 3.9% for HC subjects and 63.3 ± 1.3% for FM subjects (p = 0.013).  Note that at the dashed line, one 
      j   ’       were no longer used for averaging, due to signal contamination. 
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Table 2.                  2, and StO2 Results for HC and FM Populations 
Parameter HC (n = 13) FM (n = 10) 
p-value 
        ’   -test) 
Baseline BF 
(ml/100 ml/min) 
2.27 ± 0.52 2.42 ± 0.76 0.876 
            2 
(ml O2/100 g/min) 
0.16 ± 0.05 0.10 ± 0.04 0.346 
Baseline StO2 
(%) 
69.1 ± 1.0 69.2 ± 0.9 0.920 
Pre-exercise BF 
(ml/100 ml/min) 
3.19 ± 1.03 2.63 ± 0.71 0.444 
   -            2 
(ml O2/100 g/min) 
0.07 ± 0.02 0.08 ± 0.03 0.690 
Pre-exercise StO2 
(%) 
68.0 ± 1.6 67.9 ± 0.93 0.947 
Plateau BF 
(ml/100 ml/min) 
10.71 ± 3.91 4.83 ± 1.42 0.018* 
           2 
(ml O2/100 g/min) 
0.35 ± 0.09 0.16 ± 0.05 0.002* 
Plateau StO2 
(%) 
57.1 ± 3.9 63.3 ± 1.3 0.013* 
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CHAPTER 6: DISCUSSION AND CONCLUSIONS 
 
This chapter begins with a discussion of the results from the two studies: the 
validation of the protocol in young healthy subjects (Chapter 6.1), and the application of 
the technique to a fibromyalgia population (Chapter 6.2).  A comparison of baseline BF  
   2  S  2             w                                                            
6.3.  Next potential sources of error and challenges to the measurement technique are 
discussed in Chapter 6.4, including the influence of myoglobin on the optical signal, the 
influence of skin and adipose tissue, and the error introduced by assuming constant 
                     γ   T                                      S/D S             
compared to alternate modalities are reviewed in Chapter 6.5, and ideas for improvement 
of the gating algorithm are introduced in Chapter 6.6.  Finally, a summary of conclusions 
regarding the reliability and applicability of the technique is given in Chapter 6.7. 
 
6.1  Validation Results from Young Healthy Subjects Compared to Literature 
The feasibility of this technique for monitoring absolute hemodynamic and metabolic 
responses in exercising muscle was assessed by comparison to results found in the 
literature using a variety of measurement techniques.  For validation of plateau values 
towards the end of exercise, studies were investigated that employed dynamic forearm 
exercise within the same intensity range as the protocol described in Chapter 3.  
Comparisons for BF and    2 are presented in Table 3.  Because the literature studies 
with similar exercise protocol and intensity do not generally report StO2                   
       2 data are used for comparison.  As StO2                             2 
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                2 validation serves to corroborate StO2 results.  In addition, NIRS 
measurements of StO2 have been previously validated with other techniques by many 
groups, including O2 electrodes [96], 
133
Xenon clearance [97], and indocyanine green 
[98-100].   
The                    2 results were consistent with previously reported baseline 
values of BF [1, 8, 28, 29, 53, 54, 70, 76]        2 [1, 8, 28, 29, 53, 70, 76], as are the 
plateau values [1, 8, 76]   T                                               2 changes 
during exercise also agree with the general profiles found in previous exercise studies 
[68, 101, 102].  One disagreement between these response profiles                 
                                          /   2 value during the recovery period following 
exercise, relative to the resting baseline value prior to exercise (see Figures 16, 17, and 
18).  While the origin of this shift has not yet been specifically identified, it is possible 
that it may be due to increased temperature at the probe site due to accumulated heat from 
exercising muscle trapped by the adhesive tape, which may increase Brownian motion 
and flow.  Recent preliminary studies investigating the use of thinner adhesives such as 
Tegaderm®, as well as more open probe designs allowing for greater radiation of heat 
through the skin surface suggest that the shift may be mitigated by such intervention.  
Alternatively, it is possible that the light pressure from probe contact may induce a 
gradual hyperemic response [103, 104].  The shift may also be due to flow response 
differences between the microvasculature and large vessels measured by different 
modalities (e.g. DCS versus Doppler ultrasound) in different studies.  Further 
investigation is necessary to verify the cause. 
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Table 3.  Comparison of Validation Study Results to Literature 
Study 
Methods for 
measuring 
BF, 
    2  
Resting BF 
(ml/100ml/ 
min) 
Exercise BF 
(ml/100ml/ 
min) 
Resting
 
   2 
(ml O2/ 
100g/min) 
Exercise
 
   2 
(ml O2/ 
100g/min) 
†
(Van 
Beekvelt 
2001)[28]  
NIRS + VO,  
NIRS + AO 
(n = 26) 
0.72 ± 0.32 n/a 0.11 ± 0.03 n/a 
†
(DeBlasi 
1994)[1] 
NIRS + VO 
(n = 11) 
1.9 ± 0.8 8.2 ± 2.9 0.10 ± 0.03 0.54 ± 0.24 
†
(Harel 
2008)[53] 
NIRS + VO 
(n = 25) 
2.55 ± 0.10 n/a n/a n/a 
††
(Van 
Beekvelt 
1999)[105]  
NIRS + VO, 
NIRS + AO 
(n = 27) 
0.719 ± 0.063 n/a 0.106 ± 0.006 n/a 
†
(Edwards 
1993)[54] 
NIRS + O2 
inspiration 
(n = 6) 
2.35 ± 1.11 n/a n/a n/a 
††
(Zelis 
1974)[77] 
Strain gauge 
VO, 
blood samples 
(n = 22) 
3.10 ± 0.27 7.10 ± 0.76 0.12 ± 0.01 0.51 ± 0.05 
††
(Arnold 
1990)[76] 
Strain gauge 
VO,  
blood samples 
(n = 8) 
2.54 ± 0.23 9.20 ± 1.08 ~0.1 ~0.75 
†
(Mottram 
1955)[29] 
Strain gauge 
VO, 
blood samples 
(n = 16) 
2.9 
(0.09 – 0.52) 
n/a 0.24 ± 0.07 n/a 
††
(Gurley 
2012 – 
present 
study) 
NIRS/DCS + 
VO, 
NIRS/DCS + 
AO 
(n = 9) 
1.76 ± 0.42 8.93 ± 2.81 0.11 ± 0.03 0.57 ± 0.13 
 
†Study results are represented as (mean ± SD). ††Study results are represented as (mean ± SE).  Results 
presented without ranges are inferred from figures (i.e., values were not specifically stated in text). 
Measurements are on forearm flexor muscles of healthy adults.  Studies including exercise data are for 
protocols which involve light/moderate rhythmic exercise at a similar intensity to that presented in the 
present study.  Venous and arterial occlusion methods are represented as VO and AO, respectively. ‘ / ’  
not applicable. 
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6.2  Results from Fibromyalgia Study 
 Tissue blood flow, oxygenation, and metabolism have all been previously investigated 
in fibromyalgia populations by means of Doppler ultrasound [5], laser Doppler [86, 90], 
biopsy [85, 89, 91, 92], dynamic fluorescence videomicroscopy [87], laser fluxmetry 
[88], O2 electrodes [93], and 
31
P-MRS [95].  Findings are controversial, and no study has 
investigated all three parameters (i.e.,        2, and StO2) simultaneously, noninvasively, 
and continuously during exercise.  The present study investigated the feasibility of using 
a novel hybrid optical instrument and calibration protocol to investigate such parameters 
in FM and age-matched HC subjects during exercise.  The results indicate that the 
applied technology has the potential to differentiate group differences and may fill a void 
in fibromyalgia research that other technologies cannot. 
All subjects’      displayed similar trends in response to handgrip exercise          
   2 increased in response to metabolic demand induced by exercise, and StO2 
correspondingly decreased as more oxygen was consumed from the tissue.  In the study, 
no significant difference was found between HC and FM populations           2, and 
StO2 when comparing data points from 30 s of resting baseline data before exercise, but a 
significant difference was evident in all three variables from the last 30 s of exercise (see 
Section 5.4).  In addition, the physiological profiles (see Figures 22, 23, and 24) 
qualitatively suggest a significant difference in        2, and StO2 response to 50% MVC 
exercise between the two groups.  Variables recover quickly following the end of 
exercise, suggesting that it may be difficult to observe differences between populations 
by only monitoring post-exercise data [5], further emphasizing the importance of 
quantifying muscle hemodynamic and metabolic responses during exercise. 
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The significant difference in plateau BF between HC and FM populations evident in 
the study results shows that FM subjects do not reach peak flows as high as HC subjects 
in response to the same                           T     w      2 increase and lower 
StO2 decrease in FM subjects during exercise indicate that there may also be some 
deficiency in oxygen utilization, which may be associated with poor mitochondrial 
function [106].   
While the data presented shows that there is lower increase in           2, and lower 
decrease in StO2 in FM subjects in response to exercise, it should be noted that there is a 
significant difference in the initial MVC between the groups.  Consequently, the two 
groups had differing energy outputs during the exercise period.      w   w           
                             w                        2, which additionally translates 
to a lower flow requirement for the working muscle [107].  The difference in MVC may 
be attributed to deconditioning due to inactivity or the disease state itself.  Although the 
FM subjects in this study were fairly fit, and had relatively comparable activity levels to 
the HC subjects, specific activities were not evaluated.  For example, it is possible that 
the forearm muscle groups were less utilized than muscles of the leg           j    ’ 
normal exercise routine, and were therefore more subject to deconditioning.  It is also 
possible         j    ’ gave varying levels of effort within the population. To ensure each 
subject was contracting at maximal voluntary effort, an interpolated twitch technique may 
be used in future [108].  T     w                              w                    
       2, or StO2.  However, the extent to which this difference in MVC impacts the 
significance of the difference observed in the outcome variables has not yet been 
clarified, and requires further rigorous statistical analysis.  To fully understand the 
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differences between HC and FM exercise response, groups of subjects with similar MVC 
should be tested to eliminate the effect of deconditioning that is commonly seen in FM 
patients [109].  In addition, larger groups of subjects should be recruited to ensure the 
significance of population differences and reduce the magnitude of the error bars in 
Figures 22, 23, and 24. 
 
6.3  Comparison of Young and Older Healthy Subjects 
                                                       2, and StO2 in both the 
young and older healthy controls (Table 4) shows that values were very similar between 
healthy populations.  This is in line with the findings of previous studies investigating 
hemodynamics/metabolism in response to aging [110, 111].  MVC was slightly, though 
not significantly lower in older HC, while the other parameters showed no significant 
differences.  The plateau values cannot be reasonably compared between old and young 
healthy subjects due to the differing intensity exercise protocols (50% MVC versus 25% 
MVC), and are thus excluded from this comparison.  In future studies, it may be 
interesting to investigate both young and older subject populations using the same 
exercise protocol to determine group differences.  Larger subject populations may be able 
to more clearly define whether aging itself has an effect on muscle hemodynamics and 
metabolism. 
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Table 4.  Comparison between Young and Older Healthy Subjects 
Baseline Parameters 
Young HC  
(n = 9) 
Older HC  
(n = 13) 
p-value 
        ’   -test) 
BF (ml/100 ml/min) 1.76 ± 0.4 2.27 ± 0.52 0.448 
   2 (ml O2/100 g/min) 0.12 ± 0.02 0.16 ± 0.05 0.518 
StO2 (%) 68.0 ± 1.0 69.1 ± 1.0 0.464 
MVC (N·m) 27.3 ± 0.6 24.14 ± 0.84 0.189 
 
6.4  Study Limitations 
Influence of Myoglobin on Oxygenation Measurements 
 In optical measurements of muscle tissue, there is some expected contamination of the 
signal due to the presence of cellular myoglobins, which have very similar optical spectra 
as hemoglobins [33].  Because of this overlap, the presence of both chromophores cannot 
be readily separated by NIR optical measurements.  Many authors have argued the 
importance of this contamination, and most agree that NIR signals originate primarily (> 
90%) from hemoglobins [33, 112, 113].  
The technique developed in this study focuses on muscle oxygen consumption under 
moderate working conditions.  Myoglobins have a much higher affinity for oxygen than 
hemoglobins [114], and for the mild physiological manipulations presented in this work, 
it is expected that myoglobins would remain mostly oxygenated.  Therefore, dynamic 
oxygenation changes presented in these results may be viewed as a combined hemoglobin 
and myoglobin deoxygenation, with a minimal contribution from myoglobins.  
Furthermore, it is reasonable to expect that flow measurements (DCS) are not affected by 
myoglobin contamination, as myoglobins reside statically in the muscle tissues.  
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Detectable flow changes, by contrast, are determined from the moving red blood cells 
within the vasculature. 
 
Influence of Adipose Tissue Thickness and Skin Blood Flow 
 One challenge facing NIR optical measurements is the influence of adipose tissue 
thickness (ATT), particularly in subjects with a higher BMI than average.  The 
penetration depth of near-infrared light in biological tissue is roughly half that of the 
source-detector separation [28].  Although fat has low absorption in the NIR range [1], if 
the ATT layer is sufficiently thick, a larger portion of the detected signal could 
potentially originate from the skin and fat, and may therefore distort the true 
hemodynamic measurement of muscle.  The measurements acquired in this study utilized 
a source-detector separation of 2.0 cm, which correlates to a probing depth of ~1 cm.  
The average ATT for the young healthy subject population was 1.5 ± 0.2 mm, and 3.1 ± 
0.4 and 2.9 ± 0.4 for the FM and HC populations, respectively.  This ATT is considerably 
less than this penetration depth, suggesting that the NIR light adequately probes muscle 
tissue.  Previous work has shown that for a source-detector separation of 2 cm or greater, 
the contribution of the skin is < 5% of total light absorption, and the detected signal is 
mainly from muscle tissue [115].  Some researchers in the field have attempted to correct 
for light absorption in superficial tissues by using a two-layer model [33, 116].  Others 
have developed algorithms derived from Monte Carlo simulations with in vivo 
measurements [117] aimed at correcting for variation in measurement sensitivity due to 
ATT.  These algorithms may be useful to employ in future work, especially where the 
subject population has highly varied ATT, or when investigating deeper muscle tissue.  
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T                w     ’        [115] imply, however, that up to the ATT observed in 
thi         ~3         S/D S                                             10       
                                        w     TT        2 or BF was observed for any 
population.  It is therefore reasonable to assume that skin and ATT did not adversely 
influence the measurements. 
 
Influence of γ Assumption 
                                 2 (see Section 2.4), the percentage of blood contained 
                           γ  w                        w                            
change in blood volume during exercise, which manifests as an increase in [tHb] (average 
~20% in the young healthy population).  Because absorption is high in larger vessels, 
NIRS/DCS signals originate primarily from the arterioles, capillaries, and venules of the 
microvasculature [26].  It may be therefore assumed that the detected blood volume 
increase is due to changes in these small vessels. 
Part of the observed volume increase is likely due to capillary recruitment, a normal 
physiological event which increases the area for metabolic exchange within muscle in 
response to increased demand from exercise [118].  Previous work in mathematical 
modeling of NIRS measurements [119] suggests that changes in blood volume during 
exercise are primarily due to the changes in number of microvascular units perfused, and 
attributes the volume increase to capillaries.  In this case, capillary volume increase is 
                                                        w                           γ    
Part of the volume increase may also be due to changes in the venous compartment 
during exercise.  Venules are considerably more compliant than arterioles, which makes 
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them more capable of accommodating volume changes.  To evaluate the maximum 
                                 γ                                w                   
volume (Δ[tHb]) is due solely to changes in the venous compartment (Vv), while the 
volume in the arterial compartment remains constant (Va).  In this case an average ~20% 
Δ[tHb] (now indicative of ΔVv  w             γ           w     γ =  v/(Vv+Va), see 
Section 2.4       γrest ≈ 67  [13]    γexercise ≈ 73    T    γ                                 
in r   2                ~7  [ γrest/γexercise – 1) × 100].  Considering the fact that r   2 
increases several fold during exercise (see Figure 17), the minor variation introduced by 
                       γ                                                              
              γ w                    2 measurement, as BF is measured directly by the 
D S w                    γ  
 
6.5  Advantages and Disadvantages of NIRS/DCS 
The NIRS/DCS protocol developed in this study holds great promise for investigation 
of local hemodynamics and metabolism in muscle during exercise.  However, one should 
consider the disadvantages as well as the benefits compared to alternative measurement 
techniques.   
The primary advantage of NIRS/DCS technology is that it is entirely noninvasive, 
making the technique ideal for research purposes, especially with fragile patient 
populations, or pediatrics.  Compared to catheterization or blood sampling [29] for    2 
measurement, NIRS/DCS requires much less setup and training, and is significantly more 
comfortable for the subject.  The instrumentation of NIRS/DCS technology is also quite 
portable, which makes it an ideal diagnostic tool for subjects with limited mobility.   
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The running cost of a NIRS/DCS hybrid instrument is very inexpensive compared to 
other techniques which evaluate local perfusion and oxygen consumption [15].  PET, 
perfusion MRI, and 
31
P-MRS all require significant initial investment, and consecutive 
measurements are expensive and require well-trained technicians.  NIRS/DCS can easily 
be used for repeated measurements at very minimal cost.  This is particularly beneficial 
in a research environment, where trial and error is an integral and unavoidable part of 
many studies. 
This protocol also has the advantage of allowing continuous measurement during 
exercise.  Many previous efforts using optical technology to evaluate hemodynamic and 
metabolic response to exercise have focused on monitoring values before and following 
exercise, due to the scattering effects of muscle motion [50], or the temporal limitations 
of measuring BF or    2 via occlusion.  It has been shown, however, that these dynamic 
parameters rapidly return to baseline following the end of exercise, or even exhibit 
hyperemic response in the case of heavy exercise [68].  Without continuous monitoring 
during and immediately following exercise, physiologically useful information may be 
lost between measurements. 
NIRS/DCS is limited to measuring local perfusion under the probe site in the 
microvasculature.  In some cases, measuring local flow can be preferable to monitoring 
limb flow, as muscle groups in the limbs can exhibit a great deal of heterogeneity in 
hemodynamic/metabolic response with aging or disease [17].  However, if a specific 
application requires quantification of regional or limb flow, measurement must be 
performed by monitoring the larger vessels.  In this case, Doppler ultrasound is a popular 
method for measuring flow through major arteries.  While this method is also 
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noninvasive and portable, it requires precise probe placement in relation to the vessel, 
which can become easily dislodged during exercise.  To acquire muscle    2 
measurement in conjunction with Doppler ultrasound by the Fick method, additional 
blood sampling is required.  These regional measurements are also not necessarily 
reflective of actual delivery and utilization of oxygen in local skeletal muscle [31]. 
Another restriction to the application of NIRS/DCS technology during exercise is that 
measurement is limited to only the relaxation phase of rhythmic exercise.  By contrast, 
ultrasound Doppler can monitor flow throughout the entire contraction/relaxation cycle 
[15].  Flow is much higher in major arteries during relaxation compared to contraction 
[120], and it has been shown that arterial inflow occurs almost exclusively between 
contractions [121].  During contraction, microvascular perfusion is inhibited in part 
because of increased intramuscular pressure and extravascular compression [50].  
Because NIRS/DCS monitors only the microvasculature, it is reasonable to confine BF 
and    2 to the relaxation phase when using this measurement technique. 
 
6.6  Future Improvements for Gating Algorithm 
 The gating algorithm developed for this study relies on the availability of a control 
signal from a dynamometer.  In some cases, a dynamometer may not be readily available, 
or accessible, particularly for patients with limited mobility.  In addition, the position of 
the dynamometer lever is a secondary measurement of muscle contraction.  A more direct 
measure of muscle contraction status, such as EMG, would allow for more precise timing 
of data acquisition.  Additionally, automatic initiation of the algorithm would be an 
effective solution to reduce the noise seen at the onset of exercise (see Figures 13, 14, and 
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15).  Ideally, in future development of this protocol, EMG will be incorporated into the 
instrumentation as an alternative method to dynamometer-based signal control, and the 
gating algorithm will be fully automated. 
 
6.7  Conclusions 
 This study demonstrates the novel application of NIRS and DCS technologies to 
continuously monitor absolute local muscle hemodynamic and metabolic parameters 
during exercise in a young healthy population, an older FM subject population, and an 
older age-matched healthy population.  Previous problems with motion artifact during 
exercise were addressed with the use of an embedded software gating algorithm which 
monitored the muscle contraction status to determine appropriate times for data 
acquisition.   
The results of the validation study in a young healthy population were consistent with 
previous literature findings, and the results of the fibromyalgia study sh w               
                                              2, and StO2 at the end of moderate exercise.  
Although the results of this study are encouraging, further experimentation is required to 
fully validate the technique.  The protocol has only been used with mild intensity 
exercise, and validation is of a qualitative nature (literature comparison).  To fully 
establish the reliability of the technique, a range of exercise intensities and durations 
should be investigated, with concurrent measurement by another established modality 
(e.g. ASL-MRI, 
31
P-MRS).  Concurrent measurement would allow for quantitative multi-
point comparison with thorough statistical analysis.  A larger subject population would be 
desirable to reduce the perceived error due to normal physiological variation. 
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The results from the FM study indicate that the technology and protocol are suitable 
for monitoring hemodynamic and metabolic parameters in an older disease population, 
and can distinctly identify group differences.  While the results of the study are 
inconclusive related to the pathophysiology underlying FM, due to the confounding 
variable of MVC, the study shows that the technique may be highly applicable to future 
investigations involving exercise response of patients diagnosed with FM.  To further 
verify differences between the disease population and their healthy counterpart, a more 
carefully selected contingent of subjects with similar physical characteristics should be 
assessed.  Larger groups may also help verify the validity of the observed differences, 
and reduce natural inter-subject variation. 
Because muscle function is closely linked to oxidative metabolism and flow 
regulation, this technique is highly relevant for investigation of muscle physiology and 
pathology.  The technique finds broad application to medical research, exercise 
physiology, sports medicine, disease diagnosis, and treatment evaluation.  As 
spectroscopic technologies improve, this technique will become more accessible, with 
higher quality real-time data.  The advantages suggest that NIRS/DCS would be an 
attractive alternative for more expensive or invasive methods of BF, StO2         2 
quantification.   
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 CHAPTER 7: SUMMARY AND PERSPECTIVES 
 
In summary of this research study, I have presented a novel method for quantifying 
absolute muscle BF, tissue blood                     2 simultaneously during rhythmic 
exercise, and demonstrated the potential application of the technique to investigating 
pathophysiology of disease which affects skeletal muscle.  The method relies on a hybrid 
NIRS/DCS instrument for measurement, which was developed and built in our lab.  
Several facets of the design and completion of this study included my own contributions.  
These include design, construction, and integration of DCS photodetector power supply 
electronics (Chapter 2.3), design of the relative signal calibration protocol (Chapter 3.3), 
design of the exercise protocol (Chapter 3.4), co-development of the gating algorithm 
(Chapter 3.5), subject recruitment and acquisition of data in both a young healthy 
population, as well as FM subjects with age-matched HC subjects (Chapters 4 and 5), and 
general methods of data analysis (Chapters 4 and 5).  The results of the validation study 
in young healthy subjects have also been peer-reviewed and published [122]. 
T                                        ’                                            
                       2), the oxygen supply (BF), and the oxygen balance (StO2) 
should all be evaluated simultaneously.  Furthermore, it is critical to monitor the dynamic 
profiles of these variables in response                                                     
                                                   q                  S     D S      
                                                                                         
                     2.  The hybrid instrument developed in our lab combines the two 
spectroscopies in one streamlined measurement, providing a wealth of information that 
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gives a more complete picture of the local oxygenation kinetics within skeletal muscle 
than traditional methods.  
This study has effectively addressed previous problems associated with DCS-based 
measurements, including quantification of relative signals and removal of motion artifact 
from skeletal muscle contraction.  While the occlusion techniques used in the protocol to 
determine absolute baseline           2 are not new, the application to calibration of the 
direct but relative measurement during exercise has never been investigated, to the 
      ’     w                        absolute quantification of all presented            
        2, and StO2) has never been achieved during exercise. 
Another novel component of this study is the application of a dynamometer-based 
software gating algorithm to reduce motion artifact.  The current algorithm is highly 
effective, but future development may further improve signal characteristics.  Alternative 
sources for input signal, as well as more automated initiation and termination need to be 
investigated.  
This study also demonstrates the first efforts to apply noninvasive optical technology 
to monitoring hemodynamics and metabolism continuously during exercise in 
fibromyalgia.  While the results are somewhat inconclusive, the study shows the potential 
for using such technology to investigate responses to such stimulus in a fragile patient 
population, and could serve as a starting point for many other investigational studies on 
vasoregulation and metabolism in fibromyalgia.  Data analysis for this study was 
achieved using custom MATLAB scripts, which read files generated by the hybri  
                        2 3                                    2, and oxygenation 
variables (e.g. StO2, [HbO2], [Hb], [tHb]) (see Chapter 4). 
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The applications of this technique are many and varied.  Normal muscle and exercise 
physiology, disease pathophysiology, diagnosis, treatment evaluation, sports medicine 
and rehabilitation all benefit from the ability to continuously monitor local hemodynamic 
and metabolic regulation.  The method and instrument are especially suited to a research 
and clinical environment, due to the noninvasive, inexpensive, and portable nature of the 
technology.  The findings of this study further push the limits of optical measurement in 
medicine. 
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APPENDIX A: GLOSSARY 
 
SYMBOLS 
α    Ratio of Dynamic to Static Scatterers (0-1) 
ac    Modulated Light Amplitude 
C    Hemoglobin Concentration of Whole Blood 
γ    Percentage of Blood Volume Contained in the Venous Compartment 
D    Photon Diffusion Constant 
DB   Effective Diffusion Coefficient 
dc    Average Light Intensity 
g1    Normalized Electric Field Temporal Autocorrelation Function 
G1    Unnormalized Electric Field Temporal Autocorrelation Function 
g2    Normalized Intensity Temporal Autocorrelation Function 
I    Intensity 
k0    Wavevector of Photons in Medium (k0 = 2π /λ  
λ    Wavelength 
n    Ratio of Sample and Air Index of Refraction 
φ    Phase Modulation of NIR Light 
r    Source-detector Separation 
r    Position Vector 
ρ    Source-detector Separation 
<Δ 2 τ >  Mean- q     D               S                 τ 
Sac   Slope of r vs. ln(ac·r
2
) Curve 
Sdc   Slope of r vs. ln(dc·r
2
) Curve 
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Sφ    S             φ       
S0    Source-light Distribution 
τ    Correlation Function Decay Time 
µa    Absorption Coefficient 
µs’   Reduced Scattering Coefficient 
[x]   Concentration of x 
v    Speed of Light in Medium 
Va    Blood Volume in the Arterial Compartment 
Vv    Blood Volume in the Venous Compartment 
ω    Angular Frequency of Modulation 
 
TERMS 
APD   Avalanche Photodiode 
ASL-MRI Arterial Spin-Labeled Magnetic Resonance Imaging (Perfusion MRI) 
ATT   Adipose Tissue Thickness 
BF   Blood Flow 
BFI            w        αDB) 
CW   Continuous Wave 
DCS   Diffuse Correlation Spectroscopy 
DLS   Dynamic Light Scattering 
DWS   Diffusing Wave Spectroscopy 
FD   Frequency Domain 
FM   Fibromyalgia 
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Hb   Deoxy-hemoglobin 
HbO2   Oxy-hemoglobin 
HC   Healthy Control 
MVC   Maximal Voluntary Contraction 
NIR   Near-Infrared 
NIRS   Near-Infrared Spectroscopy 
[O]a   Arterial Oxygen Concentration 
[O]v   Venous Oxygen Concentration 
OEF   Oxygen Extraction Fraction 
31
P-MRS 31-phosphorus Magnetic Resonance Spectroscopy 
PET   Positron Emission Tomography 
PMT   Photomultiplier Tube 
RBC   Red Blood Cell 
SNR   Signal to Noise Ratio 
SaO2   Arterial Blood Oxygen Saturation 
StO2   Tissue Blood Oxygen Saturation 
TD   Time Domain 
tHb   Total Hemoglobin 
   2   Oxygen Consumption Rate 
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